stocktools
Dilution profile // every instrument, one screen, from SEC filings

BIO KEY INTERNATIONAL INC (BKYI)

CIK 1019034 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed signals (overhead supply)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
MEDIUM$6.1M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
one or more live registrations had no structured fee data, so the true total is AT LEAST this
Overhead supply
HIGHwarrants = 61% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
LOW-88% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
a reverse-split-sized cliff is in this window; read the chart
Cash need
HIGH~5.8 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)
the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2020-08-122026-06-19

Latest: 1.1M shares as of Jun 19, 2026 (10-Q). Share count fell from 66.4M to 6.1M between Nov 11, 2016 and Mar 28, 2017, a pattern consistent with a reverse split (roughly 1-for-11); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

TrancheWarrantsExercise priceTermNotes
New Warrants618,334$10.25y—
Outstanding Warrants103,056$18.5——
Existing Warrantsnot tagged$10.2——

Tranches exactly as the company dimensioned them in its 10-Q filed Jun 22, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.

Warrants outstanding: 664,750 underlying shares, as reported Dec 31, 2025 (10-K).

Reported exercise price: $1.5 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $1,206 as of Sep 30, 2016.

Down-round (price protection) accounting has been tagged in this filer’s XBRL: some instrument carries repricing protection. Which tranche requires reading the exhibits.

Rough fully diluted estimate: 1.8M = 1.1M O/S + 664,750 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Jun 22, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding1.1MJun 19, 2026
+ New Warrants (if exercised)618,334Oct 27, 2025
+ Outstanding Warrants (if exercised)103,056Sep 12, 2024
Fully diluted estimate1.8M+66.5% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

Registered offering capacity on live registrations: $6.1Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-1Nov 21, 2025$6.1M registeredfiling →
S-1Apr 25, 2025no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
S-1Oct 11, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 1 executed · 1 registered.

UPDATEDec 2, 2025Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEDec 1, 2025SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDNov 21, 2025S-1 registration — capacity to sell shares, not a sale yetS-1 →
EXECUTEDOct 30, 2025Unregistered share sale disclosed (8-K item 3.02)8-K →
UPDATEMay 12, 2025Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEMay 5, 2025SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDApr 25, 2025S-1 registration — capacity to sell shares, not a sale yetS-1 →
EXECUTEDJan 16, 2025Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDDec 3, 2024Unregistered share sale disclosed (8-K item 3.02)8-K →
UPDATEOct 25, 2024Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEOct 22, 2024SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDOct 11, 2024S-1 registration — capacity to sell shares, not a sale yetS-1 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full BKYI workspace